The evidence base for interventions to slow the progression of chronic kidney disease: Medical interventions. Jonathan Evans Paediatric Nephrologist

Similar documents
16.1 Risk of UTI recurrence in children

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Urinary tract infections in children with CAKUT and introduction of the PREDICT trial Giovanni Montini, Bologna, Italy.

Medical Management of childhood UTI and VUR. Dr Patrina HY Caldwell Paediatric Continence Education, CFA 15 th November 2013

Management of early chronic kidney disease

Vesicoureteral Reflux: The Difficulty of Consensus OR Why Can t We All Just get Along?

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Clinical and laboratory indices of severe renal lesions in children with febrile urinary tract infection

Chronic Kidney Disease

Why is the management of UTI so controversial? Kjell Tullus Consultant Paediatric Nephrologist

Is antibiotic prophylaxis of any use in nephro-urology? Giovanni Montini Pediatric Nephrology and Dialysis Unit University of Milan Italy

Recurrent Pediatric UTI Revisited 2013

UTI and VUR Practical points and management Kjell Tullus Consultant Paediatric Nephrologist

How to Predict the Development of Severe Renal Lesions in Children with febrile UTI?

Urinary tract infections, renal malformations and scarring

10. Diagnostic imaging for UTI

Dr.Nahid Osman Ahmed 1

Applying clinical guidelines treating and managing CKD

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care

Nursing Care for Children with Genitourinary Dysfunction I

Professor Suetonia Palmer

CHRONIC KIDNEY DISEASE DIAGNOSIS

Giovanni Montini has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

Doncaster & Bassetlaw. AKI guidelines for primary care

Pediatric urinary tract infection. Dr. Nariman Fahmi Pediatrics/2013

UTI Update: Have We Been Led Astray? Disclosure. Objectives

Elevated Serum Creatinine, a simplified approach

The National Quality Standards for Chronic Kidney Disease

Urinary tract infection. Mohamed Ahmed Fouad Lecturer of pediatrics Jazan faculty of medicine

Chronic Kidney Disease for the Primary Care Physician in What do the Kidneys do? CKD in the US

Chronic Kidney Disease. Paul Cockwell Queen Elizabeth Hospital Birmingham

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

CKD and risk management : NICE guideline

Cortical renal scan in febrile UTI: Established usefulness and future developments

Chronic Kidney Disease in Primary Care

Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus

UTI are the most common genitourinary disease of childhood. The prevalence of UTI at all ages is girls and 1% of boys.

Prescribing Guidelines for Urinary Tract Infections

Clinical guideline Published: 22 August 2007 nice.org.uk/guidance/cg54

H(a)ematuria. FX Keeley Consultant Urologist Bristol Urological Institute

Hot Topics in Diabetic Kidney Disease a primary care perspective

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George

Chronic Kidney Disease

OUTLINE INTRODUCTION EPIDEMIOLOGY CLASSIFICATION DIAGNOSIS AETIOLOGY MANAGEMENT FINANCIAL BURDEN OF ESRD SCREENIG GUIDELINE CONCLUSION

Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree

Paediatric Nephrology

Vesicoureteral Reflux (VUR) in Children Where are we in 2014?

Primary Care Approach to Management of CKD

UTI and VUR practical points and management

Alterations of Renal and Urinary Tract Function

Launch Meeting 3 rd April 2014, Lucas House, Birmingham

The Evolving Role of Antibiotic Prophylaxis for Vesicoureteral Reflux. Stephen Canon, MD Children s Urology

Current Trends in Pediatric GU Imaging European Perspective

Long-Term Clinical Follow up of Children with Primary Vesicoureteric Reflux. C.K. Abeysekara, B.M.C.D. Yasaratna and A.S.

UTIs in children ( with controversies ) By Dr. Lindokuhle Mahlase

Thanks to our Speaker!

Bulletin Independent prescribing information for NHS Wales

CHRONIC KIDNEY DISEASE DIAGNOSIS

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care

Stages of Chronic Kidney Disease (CKD)

It is an infection affecting any of the following parts like kidney,ureter,bladder or urethra

Reducing proteinuria


Lower Urinary Tract Infection (UTI) in Males

Topic 1 - Management of vesicoureteral reflux in the child over one year of age

Urinary Tract Infections in Children: What We Know and What We Don t

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Vesicoureteral reflux and reflux nephropathy

PYELONEPHRITIS. Wendy Glaberson 11/8/13

Scott Williams, MD Pediatric Nephrology OLOL Children s Hospital September 29, Controversies in Urinary Tract Infections

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Centre for Clinical Practice Surveillance Programme

Epidemiology of CKD in Children

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Nephrology

Acute Kidney Injury (AKI) Undergraduate nurse education

Urinary Tract Infections in Infants & Toddlers: An Evidence-based Approach. No disclosures. Importance of Topic 5/14/11. Biases

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Chronic Kidney Disease The 6 Pillars. Dr. Tiina Podymow Associate Professor Division of Nephrology McGill University Health Centre

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Identifying and Managing Chronic Kidney Disease: A Practical Approach

Faculty/Presenter Disclosure

The McMaster at night Pediatric Curriculum

NORTHERN IRELAND GUIDELINES FOR MANAGEMENT OF CHRONIC KIDNEY DISEASE

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease

Session 9: Optimizing the Management of Patients with Chronic Kidney Disease Learning Objectives

Review Article Vesicoureteral Reflux, Reflux Nephropathy, and End-Stage Renal Disease

Maolynne Miller Paediatric Nephrologist UHWI Jamaica Kidney Kids Foundation/ International Paediatric Nephrology Association 1st Jamaican Paediatric

THE KIDNEY AND SLE LUPUS NEPHRITIS

Interventions to reduce progression of CKD what is the evidence? John Feehally

Chronic Kidney Disease Management for Primary Care Physicians. Dr. Allen Liu Consultant Nephrologist KTPH 21 November 2015

Guidelines for the management of urinary tract infections in children 0-17 years

Managing Patients with CKD in Primary Care: A Shared Care Pathway. 5 th April 2018

P. Brandstrom has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

NICE support for commissioning for urinary tract infection in infants, children and young people under 16

Effective Health Care Program

Liverpool experience of Community AKI care

Transcription:

The evidence base for interventions to slow the progression of chronic kidney disease: Medical interventions Jonathan Evans Paediatric Nephrologist

CKD in adults Often unrecognised Preventable Major cardiovascular risk

Evidence, broadly construed, is anything presented in support of an assertion. This support may be strong or weak.

Preventative measures for CKD 3 0 Mx / prevent Complications 2 0 Modify Disease - BP/Proteinuria/ACEI, Rx Chronic GN 1 0 Prevent Disease lifestyle, AUTA screening, UTI Mx

Are we reducing the number of children with ERF through our preventative care? 350 300 250 200 150 100 New cases of ERF in UK aged <16yr (Renal Registry Report 2013) Dysplasia +/- VUR Obstructive Uropathy All other causes 50 0 1998-02 2003-07 2008-12

Prophylactic Antibiotics?

CG54 UTI in Children (2007) 1.2.3.1 Antibiotic prophylaxis should not be routinely recommended in infants and children following first UTI. 1.2.3.2 Antibiotic prophylaxis may be considered in infants and children with recurrent UTI. Long-term antibiotics for preventing recurrent urinary tract infection in children (Review) 2011 Williams G, Craig JC Long term antibiotics reduce the risk of UTI in susceptible children (+/- VUR) but the benefit is small and there is increased risk of antimicrobial resistance Nitrofurantoin most effective but high incidence of AE

Interventions for primary vesicoureteric reflux(review) 2011 Nagler V, Williams G, Hodson E Craig JC Author Conclusions : 1. long-term, low-dose antibiotics did not reduce the number of repeat symptomatic or febrile UTIs in children with VUR. 2. Antibiotic prophylaxis associated with 3X incidence of resistance 3. Considerable heterogeneity in the analyses and inclusion of only one adequately blinded study, made drawing firm conclusions challenging. 4. Antibiotic prophylaxis significantly reduced the risk of developing new or progressive renal damage, but assuming an 8% baseline risk, 33 children would need long-term antibiotic prophylaxis to prevent one more child developing kidney damage over the course of two to three years. So if you believe the results the question is... Is the damage (progressive or new renal scar) avoided sufficient to justify long term Rx

Prompt Treatment of UTI as recommended by NICE & AAP Guidelines? Does prompt treatment of urinary tract infection in preschool children prevent renal scarring: mixed retrospective and prospective audits. Coulthard 2013 Treating UTI in 3 days, halves the risk of acquiring kidney scars. Incidence of focal scars on DMSA reduced from ~ 0.4% to 0.2% Risk of scars increased with VUR This reduction in scarring rates could not have been detected if the NICE CG had been implemented locally.

Early Treatment of Acute Pyelonephritis in Children Fails to Reduce Renal Scarring: Data From the Italian Renal Infection Study Trials. Hewitt (2008) Pooled results from 2 prospective RCTs analysing ~300 children with first UTI & acute pyelonephritis with rpt DMSA at 12 months No change in % scarring with delay in treatment (1-5d) No difference in % scarring at different ages Fever normalised within average of 1.6 days we recommend prompt treatment of febrile UTIs to facilitate rapid recovery from the acute illness,

Antibiotics to prevent CKD Variable evidence they work! But no proof they don t in my patient! So. Treat UTIs Consider prophylaxis Consider stopping prophylaxis sooner

Mechanisms of CKD progression

1. Recognise child at risk of progressive CKD 2. Know what to do 3. Do it well Risk Factors for Progression of CKD Chronic Glomerulonephritis Progressive disorders (e.g ARPKD, Cystinosis, Alports) Uropathies (obstruction, infection, bad bladder) Bilateral renal disease/poor renal growth Obesity Advanced CKD (stage 3+) Hypertension Proteinuria Anaemia Hyperlipidaemia Hyperphosphataemia

Creatinine Inaccurate assay Tubular secretion Reciprocal relationship to GFR Insensitive at detecting low GFR

egfr is Egfr Lab & age specific value for K?

BP & Proteinuria Proteinuria PCR or ACR EMU or random PCR <15 Normal 15-50 Mild >50 Clinical >250 Nephrotic

KDIGO categories

1. Recognise child at risk of progressive CKD 2. Know what to do 3. Do it well

Delaying CKD progression - adults Hypertension & glomerular hyperfiltration cause progressive nephron loss Proteinuria indicates accelerated decline Treatment Good BP control delays CKD progression Reducing proteinuria also delays CKD ACEI or ARBs are best antiproteinuric, antiinflammatory, antifibrotic ACEI reduce rate of decline by ~ 50% What about children?

Strict BP control & Progression of Renal Failure in Children All hypertensive, CKD 2-4 & treated with ACEI Additional antihypertensives to achieve Conventionnal BP control (< 90%ile) Intensified BP control (< 50%ile) End point = 50% reduction in egfr

KDIGO - includes children Recommend If BP >90%ile treat BP and restrict sodium intake (1C) All CKD pts considered as at risk of AKI (1C) Suggest Target BP of <50%ile (if tolerated) especially if proteinuric (2D) Use ACEI/ARB irrespective of proteinuria (2D)

1. Recognise child at risk of progressive CKD 2. Know what to do 3. Do it well child... with a disease not disease in a child

Kidney function (% of normal) change in kidney function (egfr) over time expressed as a percentage of normal 60 50 40 30 20 10 0 7 9 11 13 15 Age (years)

says The evidence base for interventions to slow the progression of chronic kidney disease: Medical interventions... Is Identify who is at risk & look after them! Treat BP well Especially if there is clinical proteinuria Use ACEI and Consider prophylactic antibiotics in children with VUR/RN Prevent AKI treat UTIs promptly, avoid dehydration and nephrotoxic drugs

There s nothing really wrong with you but I think a little surgery would make us both feel better